Trading Signals: SAGE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(SAGE Therapeutics Inc)
| SAGE latest price $71.4200 (-4.02%) ($71.2300 - $71.4200) on Mon. May. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.47% (three month average) | RSI | 53 | Latest Price | $71.4200(-4.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SAGE declines -0.4% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SAGE advance at 0% a week (0% probability) IBB(49%) IWO(44%) IWC(43%) IWM(41%) XBI(38%) | Factors Impacting SAGE price | SAGE will decline at least -1.735% in a week (0% probabilities). VIXM(-28%) UUP(-12%) VXX(-7%) UNG(-1%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.735% (StdDev 3.47%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $74.1 | 5 Day Moving Average | $72.9(-2.03%) | 10 Day Moving Average | $72.7(-1.76%) | 20 Day Moving Average | $74.1(-3.62%) | To recent high | -18.2% | To recent low | 2.1% | Market Cap | $3.709b | | | | SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. |